L&K Biomed Ltd. (KOSDAQ:156100)

L&K Biomed Revenue

L&K Biomed had revenue of 9.50B KRW in the quarter ending March 31, 2026, with 6.82% growth. This brings the company's revenue in the last twelve months to 39.53B, up 10.23% year-over-year. In the year 2025, L&K Biomed had annual revenue of 38.92B with 7.84% growth.

• Revenue (ttm): 39.53B
• Revenue Growth: +10.23%
• P/S Ratio: 2.84
• Revenue / Employee: 391.36M
• Employees: 101
• Market Cap: 112.43B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	38.92B	2.83B	7.84%
Dec 31, 2024	36.09B	6.19B	20.69%
Dec 31, 2023	29.90B	10.14B	51.28%
Dec 31, 2022	19.77B	4.39B	28.59%
Dec 31, 2021	15.37B	-3.98B	-20.58%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error